[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C. and Lordick, F. (2020) Gastric Cancer. Lancet, 396, 635-648. https://doi.org/10.1016/S0140-6736(20)31288-5
|
[3]
|
Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R. and Sitarz, R. (2020) Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences, 21, Article No. 4012. https://doi.org/10.3390/ijms21114012
|
[4]
|
Venerito, M., Link, A., Rokkas, T. and Malfertheiner, P. (2016) Gastric Cancer—Clinical and Epidemiological Aspects. Helicobacter, 21, 39-44. https://doi.org/10.1111/hel.12339
|
[5]
|
den Hoed, C.M. and Kuipers, E.J. (2016) Gastric Cancer: How Can We Reduce the Incidence of this Disease? Current Gastroenterology Reports, 18, Article No. 34. https://doi.org/10.1007/s11894-016-0506-0
|
[6]
|
Choi, Y.J. and Kim, N. (2016) Gastric Cancer and Family History. The Korean Journal of Internal Medicine, 31, 1042-1053. https://doi.org/10.3904/kjim.2016.147
|
[7]
|
Ou, J., Peng, Y., Yang, W., Zhang, Y., Hao, J., Li, F., et al. (2019) ABHD5 Blunts the Sensitivity of Colorectal Cancer to Fluorouracil via Promoting Autophagic Uracil Yield. Nature Communications, 10, Article No. 1078.
https://doi.org/10.1038/s41467-019-08902-x
|
[8]
|
Feng, W., Ding, Y., Zong, W. and Ju, S. (2019) Non-Coding RNAs in Regulating Gastric Cancer Metastasis. Clinica Chimica Acta, 496, 125-133. https://doi.org/10.1016/j.cca.2019.07.003
|
[9]
|
Biagioni, A., Skalamera, I., Peri, S., Schiavone, N., Cianchi, F., Giommoni, E., et al. (2019) Update on Gastric Cancer Treatments and Gene Therapies. Cancer and Metastasis Reviews, 38, 537-548.
https://doi.org/10.1007/s10555-019-09803-7
|
[10]
|
An, Y., Zhou, L., Huang, Z., Nice, E.C., Zhang, H. and Huang, C. (2019) Molecular Insights into Cancer Drug Resistance from a Proteomics Perspective. Expert Review of Proteomics, 16, 413-429.
https://doi.org/10.1080/14789450.2019.1601561
|
[11]
|
Fu, S., Liu, X., Luo, M., Xie, K., Nice, E.C., Zhang, H., et al. (2017) Proteogenomic Studies on Cancer Drug Resistance: Towards Biomarker Discovery and Target Identification. Expert Review of Proteomics, 14, 351-362.
https://doi.org/10.1080/14789450.2017.1299006
|
[12]
|
Wang, S.Y., Hu, H.Z., Qing, X.C., Zhang, Z.C. and Shao, Z.W. (2020) Recent Advances of Drug Delivery Nanocarriers in Osteosarcoma Treatment. Journal of Cancer, 11, 69-82. https://doi.org/10.7150/jca.36588
|
[13]
|
Shi, W.J. and Gao, J.B. (2016) Molecular Mechanisms of Chemoresistance in Gastric Cancer. World Journal of Gastrointestinal Oncology, 8, 673-681. https://doi.org/10.4251/wjgo.v8.i9.673
|
[14]
|
Wu, X., Zheng, Y., Han, B. and Dong, X. (2018) Long Noncoding RNA BLACAT1 Modulates ABCB1 to Promote Oxaliplatin Resistance of Gastric Cancer via Sponging miR-361. Biomedicine & Pharmacotherapy, 99, 832-838.
https://doi.org/10.1016/j.biopha.2018.01.130
|
[15]
|
Hsieh, M.Y., Fan, J.R., Chang, H.W., Chen, H.C., Shen, T.L., Teng, S.C., et al. (2014) DNA Topoisomerase III Alpha Regulates p53-Mediated Tumor Suppression. Clinical Cancer Research, 20, 1489-1501.
https://doi.org/10.1158/1078-0432.CCR-13-1997
|
[16]
|
Park, H., Cho, S.Y., Kim, H., Na, D., Han, J.Y., Chae, J., et al. (2015) Genomic Alterations in BCL2L1 and DLC1 Contribute to Drug Sensitivity in Gastric Cancer. Proceedings of the National Academy of Sciences of the United States of America, 112, 12492-12497. https://doi.org/10.1073/pnas.1507491112
|
[17]
|
Xu, J., Lamouille, S. and Derynck, R. (2009) TGF-β-Induced Epithelial to Mesenchymal Transition. Cell Research, 19, 156-172. https://doi.org/10.1038/cr.2009.5
|
[18]
|
Painter, J.D., Galle-Treger, L. and Akbari, O. (2020) Role of Autophagy in Lung Inflammation. Frontiers in Immunology, 11, Article No. 1337. https://doi.org/10.3389/fimmu.2020.01337
|
[19]
|
Moosavi, M.A. and Djavaheri-Mergny, M. (2019) Autophagy: New Insights into Mechanisms of Action and Resistance of Treatment in Acute Promyelocytic Leukemia. International Journal of Molecular Sciences, 20, Article No. 3559. https://doi.org/10.3390/ijms20143559
|
[20]
|
White, E. (2012) Deconvoluting the Context-Dependent Role for Autophagy in Cancer. Nature Reviews Cancer, 12, 401-410. https://doi.org/10.1038/nrc3262
|
[21]
|
Zheng, K., He, Z., Kitazato, K. and Wang, Y. (2019) Selective Autophagy Regulates Cell Cycle in Cancer Therapy. Theranostics, 9, 104-125. https://doi.org/10.7150/thno.30308
|
[22]
|
Lee, H.J., Venkatarame Gowda Saralamma, V., Kim, S.M., Ha, S.E., Raha, S., Lee, W.S., et al. (2018) Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway. Nutrients, 10, Article No. 1043. https://doi.org/10.3390/nu10081043
|
[23]
|
Chen, G., Zhang, M. and Li, Y. (2019) Research Progress in the Role of microRNA-155 in Regulation of Autophagy and Diagnosis and Treatment for Gastric Cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 44, 87-91.
|
[24]
|
Yun, C.W. and Lee, S.H. (2018) The Roles of Autophagy in Cancer. International Journal of Molecular Sciences, 19, Article No. 3466. https://doi.org/10.3390/ijms19113466
|
[25]
|
Zhang, X., Wang, S., Wang, H., Cao, J., Huang, X., Chen, Z., et al. (2019) Circular RNA circNRIP1 acts as a Microrna-149-5p Sponge to Promote Gastric Cancer Progression via the AKT1/mTOR Pathway. Molecular Cancer, 18, Article No. 20. https://doi.org/10.1186/s12943-018-0935-5
|
[26]
|
Yan, H., Qiu, C., Sun, W., Gu, M., Xiao, F., Zou, J., et al. (2018) Yap Regulates Gastric Cancer Survival and Migration via SIRT1/Mfn2/Mitophagy. Oncology Reports, 39, 1671-1681. https://doi.org/10.3892/or.2018.6252
|
[27]
|
Helleday, T., Petermann, E., Lundin, C., Hodgson, B. and Sharma, R.A. (2008) DNA Repair Pathways as Targets for Cancer Therapy. Nature Reviews Cancer, 8, 193-204. https://doi.org/10.1038/nrc2342
|
[28]
|
Amaravadi, R.K, Lippincott-Schwartz, J., Yin, X.M., Weiss, W.A., Takebe, N., Timmer, W., et al. (2011) Principles and Current Strategies for Targeting Autophagy for Cancer Treatment. Clinical Cancer Research, 17, 654-666.
https://doi.org/10.1158/1078-0432.CCR-10-2634
|
[29]
|
Usman, R.M., Razzaq, F., Akbar, A., Farooqui, A.A., Iftikhar, A., Latif, A., et al. (2021) Role and Mechanism of Autophagy-Regulating Factors in Tumorigenesis and Drug Resistance. Asia-Pacific Journal of Clinical Oncology, 17, 193-208. https://doi.org/10.1111/ajco.13449
|
[30]
|
Fang, Y.J., Jiang, P., Zhai, H. and Dong, J.S. (2020) LncRNA GAS8-AS1 Inhibits Ovarian Cancer Progression through Activating Beclin1-Mediated Autophagy. OncoTargets and Therapy, 13, 10431-10440.
https://doi.org/10.2147/OTT.S266389
|
[31]
|
Yu, Z.Y., Wang, Z., Lee, K.Y., Yuan, P. and Ding, J. (2018) Effect of Silencing Colon Cancer-Associated Transcript 2 on the Proliferation, Apoptosis and Autophagy of Gastric Cancer BGC-823 Cells. Oncology Letters, 15, 3127-3132.
https://doi.org/10.3892/ol.2017.7677
|
[32]
|
Zhu, L., Zhu, Y., Han, S., Chen, M., Song, P., Dai, D., et al. (2019) Impaired Autophagic Degradation of lncRNA ARHGAP5-AS1 Promotes Chemoresistance in Gastric Cancer. Cell Death & Disease, 10, Article No. 383.
https://doi.org/10.1038/s41419-019-1585-2
|
[33]
|
Si, Y., Yang, Z., Ge, Q., Yu, L., Yao, M., Sun, X., et al. (2019) Long Non-Coding RNA Malat1 Activated Autophagy, Hence Promoting Cell Proliferation and Inhibiting Apoptosis by Sponging miR-101 in Colorectal Cancer. Cellular & Molecular Biology Letters, 24, Article No. 50. https://doi.org/10.1186/s11658-019-0175-8
|
[34]
|
Zhang, F., Li, Q., Zhu, K., Zhu, J., Li, J., Yuan, Y., et al. (2020) LncRNA LINC00265/miR-485-5p/IRF2-Mediated Autophagy Suppresses Apoptosis in Acute Myeloid Leukemia Cells. American Journal of Translational Research, 12, 2451-2462.
|
[35]
|
Xu, J., Yang, R., Hua, X., Huang, M., Tian, Z., Li, J., et al. (2020) lncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy. Molecular Therapy Nucleic Acids, 21, 354-366. https://doi.org/10.1016/j.omtn.2020.06.010
|
[36]
|
Bermudez, M., Aguilar-Medina, M., Lizarraga-Verdugo, E., Avendano-Felix, M., Silva-Benitez, E., Lopez-Camarillo, C., et al. (2019) LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer. Frontiers in Oncology, 9, Article No. 1008. https://doi.org/10.3389/fonc.2019.01008
|
[37]
|
Ren, J., Ding, L., Zhang, D., Shi, G., Xu, Q., Shen, S., et al. (2018) Carcinoma-Associated Fibroblasts Promote the Stemness and Chemoresistance of Colorectal Cancer by Transferring Exosomal LncRNA H19. Theranostics, 8, 3932-3948.
https://doi.org/10.7150/thno.25541
|
[38]
|
Xiong, H., Ni, Z., He, J., Jiang, S., Li, X., He, J., et al. (2017) LncRNA HULC Triggers Autophagy via Stabilizing Sirt1 and Attenuates the Chemosensitivity of HCC Cells. Oncogene, 36, 3528-3540.
https://doi.org/10.1038/onc.2016.521
|
[39]
|
Sun, W., Zu, Y., Fu, X. and Deng, Y. (2017) Knockdown of lncRNA-XIST Enhances the Chemosensitivity of NSCLC Cells via Suppression of Autophagy. Oncology Reports, 38, 3347-3354. https://doi.org/10.3892/or.2017.6056
|
[40]
|
Wang, Z.H., Wang, J.H., Wang, K.Q., Zhou, Y. and Wang, J. (2020) LncRNA FEZF1-AS1 Promoted Chemoresistance, Autophagy and Epithelial-Mesenchymal Transition (EMT) through Regulation of miR-25-3p/ITGB8 Axis in Prostate Cancer. European Review for Medical and Pharmacological Sciences, 24, 2281-2293.
https://doi.org/10.26355/eurrev_202003_20494
|
[41]
|
Huang, F., Chen, W., Peng, J., Li, Y., Zhuang, Y., Zhu, Z., et al. (2018) LncRNA PVT1 Triggers Cyto-Protective Autophagy and Promotes Pancreatic Ductal Adenocarcinoma Development via the miR-20a-5p/ULK1 Axis. Molecular Cancer, 17, Article No. 98. https://doi.org/10.1186/s12943-018-0845-6
|
[42]
|
Gu, J., Wang, Y., Wang, X., Zhou, D., Wang, X., Zhou, M., et al. (2018) Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in Regulating Autophagy in Patients with Breast Cancer. Cellular Physiology and Biochemistry, 48, 194-207.
https://doi.org/10.1159/000491718
|
[43]
|
Wang, Z. and Jin, J. (2019) LncRNA SLCO4A1-AS1 Promotes Colorectal Cancer Cell Proliferation by Enhancing Autophagy via miR-508-3p/PARD3 Axis. Aging, 11, 4876-4889. https://doi.org/10.18632/aging.102081
|
[44]
|
Pan, Z., Wu, C., Li, Y., Li, H., An, Y., Wang, G., et al. (2020) LncRNA DANCR Silence Inhibits SOX5-Medicated Progression and Autophagy in Osteosarcoma via Regulating miR-216a-5p. Biomedicine & Pharmacotherapy, 122, Article ID: 109707. https://doi.org/10.1016/j.biopha.2019.109707
|
[45]
|
Li, Z., Lu, M., Zhou, Y., Xu, L., Jiang, Y., Liu, Y., et al. (2021) Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review. OncoTargets and Therapy, 14, 503-518.
https://doi.org/10.2147/OTT.S294378
|
[46]
|
Xin, L., Zhou, Q., Yuan, Y.W., Zhou, L.Q., Liu, L., Li, S.H., et al. (2019) METase/lncRNA HULC/FoxM1 Reduced Cisplatin Resistance in Gastric Cancer by Suppressing Autophagy. Journal of Cancer Research and Clinical Oncology, 145, 2507-2517. https://doi.org/10.1007/s00432-019-03015-w
|
[47]
|
Song, Z., Jia, N., Li, W. and Zhang, X.Y. (2020) LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p. OncoTargets and Therapy, 13, 10877-10887. https://doi.org/10.2147/OTT.S267915
|
[48]
|
Hu, Y, Su Y., Lei, X., Zhao, H., Wang, L., Xu, T, et al. (2020) LINC00641/miR-582-5p Mediate Oxaliplatin Resistance by Activating Autophagy in Gastric Adenocarcinoma. Scientific Report, 10, Article No. 14981.
https://doi.org/10.1038/s41598-020-70913-2
|
[49]
|
Xi, Z., Si, J. and Nan J. (2019) LncRNA MALAT1 Potentiates Autophagy Associated Cisplatin Resistance by Regulating the MicroRNA30b/Autophagy Related Gene 5 Axis in Gastric Cancer. International Journal of Oncology, 54, 239-248. https://doi.org/10.3892/ijo.2018.4609
|
[50]
|
Wang, S., Li, M.Y., Liu, Y., Vlantis, A.C., Chan, J.Y., Xue, L., et al. (2020) The Role of MicroRNA in Cisplatin Resistance or Sensitivity. Expert Opinion on Therapeutic Targets, 24, 885-897.
https://doi.org/10.1080/14728222.2020.1785431
|
[51]
|
Fu, Q., Cheng, J., Zhang, J., Zhang, Y., Chen, X., Xie, J., et al. (2016) Downregulation of YEATS4 by miR-218 Sensitizes Colorectal Cancer Cells to L-OHP-Induced Cell Apoptosis by Inhibiting Cytoprotective Autophagy. Oncology Reports, 36, 3682-3690. https://doi.org/10.3892/or.2016.5195
|
[52]
|
Nyhan, M.J., O’Donovan, T.R., Boersma, A.W., Wiemer, E.A. and McKenna, S.L. (2016) MiR-193b Promotes Autophagy and Non-Apoptotic Cell Death in Oesophageal Cancer Cells. BMC Cancer, 16, Article No. 101.
https://doi.org/10.1186/s12885-016-2123-6
|
[53]
|
Zhao, J., Nie, Y., Wang, H. and Lin, Y. (2016) miR-181a Suppresses Autophagy and Sensitizes Gastric Cancer Cells to Cisplatin. Gene, 576, 828-833. https://doi.org/10.1016/j.gene.2015.11.013
|
[54]
|
Gao, Y., Liu, Z., Ding, Z., Hou, S., Li. J. and Jiang, K. (2018) MicroRNA-155 Increases Colon Cancer Chemoresistance to Cisplatin by Targeting Forkhead Box O3. Oncology Letters, 15, 4781-4788.
https://doi.org/10.3892/ol.2018.7976
|
[55]
|
Xiao, C.R., Hong, X.L., Hu, J.S., Chen, Y.M. and Lu, Q.Y. (2017) Targeting miR155 Restores Chemotherapy Sensitivity in Drug-Resistant Myeloma Cell-Line RPMI8226/DOX Cells. Zhonghua Xue Ye Xue Za Zhi; 38, 55-59.
|
[56]
|
Tian, L., Zhao, Z., Xie, L. and Zhu, J. (2018) MiR-361-5p Suppresses Chemoresistance of Gastric Cancer Cells by Targeting FOXM1 via the PI3K/Akt/mTOR Pathway. Oncotarget, 9, 4886-4896.
https://doi.org/10.18632/oncotarget.23513
|
[57]
|
Huang, H., Tang, J., Zhang, L., Bu, Y. and Zhang, X. (2018) miR-874 Regulates Multiple-Drug Resistance in Gastric Cancer by Targeting ATG16L1. International Journal of Oncology, 53, 2769-2779.
https://doi.org/10.3892/ijo.2018.4593
|
[58]
|
Li, B., Wang, W., Li, Z., Chen, Z., Zhi, X., Xu, J., et al. (2017) MicroRNA-148a-3p Enhances Cisplatin Cytotoxicity in Gastric Cancer through Mitochondrial Fission Induction and Cyto-Protective Autophagy Suppression. Cancer Letters, 410, 212-227. https://doi.org/10.1016/j.canlet.2017.09.035
|
[59]
|
Gu, Y., Fei, Z. and Zhu, R. (2020) miR-21 Modulates Cisplatin Resistance of Gastric Cancer Cells by Inhibiting Autophagy via the PI3K/Akt/mTOR Pathway. Anticancer Drugs, 31, 385-393.
https://doi.org/10.1097/CAD.0000000000000886
|
[60]
|
Tian, H., Wang, W., Meng, X., Wang, M., Tan, J., Jia, W., et al. (2019) ERas Enhances Resistance to Cisplatin-Induced Apoptosis by Suppressing Autophagy in Gastric Cancer Cell. Frontiers in Cell and Developmental Biology, 7, Article No. 375. https://doi.org/10.3389/fcell.2019.00375
|
[61]
|
Guo, Q., Jing, F.J., Xu, W., Li, X., Li, X., Sun, J.L., et al. (2019) Ubenimex Induces Autophagy Inhibition and EMT Suppression to Overcome Cisplatin Resistance in GC Cells by Perturbing the CD13/EMP3/PI3K/AKT/NF-κB Axis. Aging, 12, 80-105. https://doi.org/10.18632/aging.102598
|
[62]
|
Lu, R., Zhao, G., Yang, Y., Jiang, Z., Cai, J. and Hu, H. (2019) Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells. Technology in Cancer Research & Treatment, 18, Article ID: 1533033819864311.
https://doi.org/10.1177/1533033819864311
|
[63]
|
Xiao, F., Ouyang, B., Zou, J., Yang, Y., Yi, L. and Yan, H. (2020) Trim14 Promotes Autophagy and Chemotherapy Resistance of Gastric Cancer Cells by Regulating AMPK/mTOR Pathway. Drug Development Research, 81, 544-550.
https://doi.org/10.1002/ddr.21650
|
[64]
|
Li, P., Hu, J., Shi, B. and Tie, J. (2020) Baicalein Enhanced Cisplatin Sensitivity of Gastric Cancer Cells by Inducing Cell Apoptosis and Autophagy via Akt/mTOR and Nrf2/Keap 1 Pathway. Biochemical and Biophysical Research Communications, 531, 320-327. https://doi.org/10.1016/j.bbrc.2020.07.045
|
[65]
|
Liu, X., Duan, C., Ji, J., Zhang, T., Yuan, X., Zhang, Y., et al. (2017) Cucurbitacin B Induces Autophagy and Apoptosis by Suppressing CIP2A/PP2A/mTORC1 Signaling Axis in Human Cisplatin Resistant Gastric Cancer Cells. Oncology Reports, 38, 271-278. https://doi.org/10.3892/or.2017.5648
|
[66]
|
Nie, Y., Liang, X., Liu, S., Guo, F., Fang, N. and Zhou, F. (2020) WASF3 Knockdown Sensitizes Gastric Cancer Cells to Oxaliplatin by Inhibiting ATG12-Mediated Autophagy. American Journal of the Medical Sciences, 359, 287-295.
https://doi.org/10.1016/j.amjms.2020.02.007
|